迈博药业-B(02181)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02181 迈博药业-B

未开盘 05-06 13:30:01

0.450

+0.000

0.00%

最高0.450	最低0.450	成交量0.00
今开0.450	昨收0.450	日振幅0.00%
总市值18.56亿	流通市值18.56亿	总股本41.24亿
成交额0.00	换手率0.00%	流通股本41.24亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02181","market":"HK","secType":"STK","nameCN":"迈博药业-B","latestPrice":0.45,"timestamp":1778045401814,"preClose":0.45,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":4124000000,"shares":4124000000,"eps":0.011500430933166184,"marketStatus":"未开盘","change":0,"latestTime":"05-06 13:30:01","open":0.45,"high":0.45,"low":0.45,"amount":0,"amplitude":0,"askPrice":0.475,"askSize":10000,"bidPrice":0.45,"bidSize":20000,"shortable":0,"etf":0,"ttmEps":0.017250646399749273,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778117400000},"marketStatusCode":0,"adr":0,"listingDate":1559232000000,"exchange":"SEHK","adjPreClose":0.45,"openAndCloseTimeList":[[1778031000000,1778040000000],[1778043600000,1778054400000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02181/wiki","defaultTab":"wiki","newsList":[{"id":"1119467089","title":"迈博药业-B 4月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1119467089","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119467089?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:38","pubTimestamp":1778056736,"startTime":"0","endTime":"0","summary":"迈博药业-B（02181）于2026年5月6日发布截至2026年4月30日止月报表。报告显示，公司注册股本维持在50,000,000,000股，面值每股0.0001美元，总额5,000,000美元，与上月持平。\n报告期末，迈博药业-B已发行股份为4,124,080,000股，无库存股份，总股本与上月保持一致，未发生新增发行、购回或注销。公司所实施的股份期权计划维持在72,670,876份期权，报告期内无行权、授出或作废记录。\n公告显示，迈博药业-B当前已符合港交所对最低公众持股量的要求，并声明遵守香港联交所《上市规则》及相关法规。本次公告由公司秘书曾浩贤先生签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110043887","title":"迈博药业-B收入大涨翻倍实现年度盈利，多元化创新药管线支撑全球化布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1110043887","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110043887?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:43","pubTimestamp":1777279421,"startTime":"0","endTime":"0","summary":"迈博药业-B于报告期内收入快速扩张并成功扭亏为盈，经营表现及整体财务状况显著改善。公司注册于开曼群岛，总部位于中国泰州及香港等地，并通过境外注册、香港上市的架构开展业务。在截至2025年12月31日止年度，公司实现营业收入6.46亿元人民币，同比增长150.2%。年内收入和盈利能力的提升推动公司实现0.57亿元净利润，较上年度1.28亿元的亏损大幅改善。销售及分销费用随市场推广投入加大而上升至4.01亿元，研发开支则由0.75亿元降至0.58亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"迈博药业-B收入大涨翻倍实现年度盈利，多元化创新药管线支撑全球化布局","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131787276","title":"迈博药业-B授予董事股份购回授权，规模达已发行股本一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1131787276","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131787276?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:37","pubTimestamp":1777279052,"startTime":"0","endTime":"0","summary":"迈博药业-B于公告中披露，将在下一次股东周年大会上寻求授予董事一般性股份购回授权，规模最多为已发行股本的10%。截至本次公告披露日期，公司已发行股份总数为4,124,080,000股，故回购上限对应约412,408,000股。公司股东周年大会将于2026年6月26日召开，届时若关于购回授权的决议案获正式通过，公司即可在授权有效期内酌情择机进行股份回购。董事会同时提醒，相关购回事项须遵守香港及开曼群岛法律要求，以及联交所上市规则的有关规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"迈博药业-B授予董事股份购回授权，规模达已发行股本一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101494222","title":"迈博药业-B3月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1101494222","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101494222?lang=zh_cn&edition=full","pubTime":"2026-04-02 17:20","pubTimestamp":1775121642,"startTime":"0","endTime":"0","summary":"迈博药业有限公司于2026年4月2日披露2026年3月股份变动月报表。报告期截至2026年3月31日，公司注册股本总额保持在50,000,000,000股，面值每股0.0001美元，合计5,000,000美元，无任何变动。股本结构维持稳定，公众持股量符合相关上市规则要求。截至报告期末，尚可发行或转让的股份期权数目与上月末保持一致。公司确认遵守香港联交所《上市规则》的相关规定，截至3月底股本无变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622854919","title":"迈博药业-B(02181)发布年度业绩 股东应占溢利5713.3万元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2622854919","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622854919?lang=zh_cn&edition=full","pubTime":"2026-03-26 19:38","pubTimestamp":1774525130,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迈博药业-B(02181)发布截至2025年12月31日止年度业绩，营业收入6.46亿元(人民币，下同)，同比增长150.2%;公司拥有人应占溢利5713.3万元，同比扭亏为盈;每股基本盈利0.01元。公告称，股东应占溢利扭亏为盈主要是由于公司毛利增加以及将未来一年可抵扣的所得税确认为递延所得税费用所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"迈博药业-B(02181)发布年度业绩 股东应占溢利5713.3万元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02181","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619162724","title":"迈博药业-B03月13日主力净流入211.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2619162724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619162724?lang=zh_cn&edition=full","pubTime":"2026-03-13 16:15","pubTimestamp":1773389746,"startTime":"0","endTime":"0","summary":"03月13日, 迈博药业-B股价涨37.25%，报收0.70元，成交金额633.7万元，换手率0.27%，振幅37.25%，量比7.32。迈博药业-B今日主力资金净流入211.9万元，上一交易日主力净流出0万元。该股近5个交易日上涨70.73%，主力资金累计净流入527.9万元；近20日主力资金累计净流入527.9万元，其中净流入天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313161932a46631c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313161932a46631c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02181","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618390412","title":"迈博药业-B03月11日主力净流入316万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2618390412","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618390412?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:15","pubTimestamp":1773216950,"startTime":"0","endTime":"0","summary":"03月11日, 迈博药业-B股价涨18.60%，报收0.51元，成交金额380.5万元，换手率0.18%，振幅25.58%，量比82.26。迈博药业-B今日主力资金净流入316万元，上一交易日主力净流出0万元。该股近5个交易日上涨27.50%，主力资金累计净流入316万元；近20日主力资金累计净流入291.2万元，其中净流入天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311161948a460aac9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311161948a460aac9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02181","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133383551","title":"迈博药业（02181）更新2月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1133383551","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133383551?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:36","pubTimestamp":1772526992,"startTime":"0","endTime":"0","summary":"迈博药业有限公司于2026年3月3日发布截至2026年2月28日的股份变动月报表。公告显示，公司本月无新增发行、购回或注销股份，各类股本保持不变。迈博药业有限公司注册股本为50,000,000,000股，每股面值0.0001美元，总注册股本约5,000,000美元。截至2月28日，公司已发行股份数量维持在4,124,080,000股，未持有任何库藏股份。公告同时确认其公众持股量满足相关上市规则的最低要求。整体而言，截至2026年2月28日，公司股本数量未发生变化。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613756197","title":"迈博药业-B股价重挫11.76% 市值跌6001.77万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613756197","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613756197?lang=zh_cn&edition=full","pubTime":"2026-02-23 15:04","pubTimestamp":1771830257,"startTime":"0","endTime":"0","summary":"2026年02月23日下午盘15时04分，迈博药业-B股票出现波动，股价急速下挫11.76%。截至发稿，该股报0.450港元/股，成交量2000股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出900港元。迈博药业-B股票所在的生物技术行业中，整体涨幅为1.23%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事癌症及自身免疫性疾病的单抗药物的研究、开发及生产的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223150417a4be43c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223150417a4be43c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135557592","title":"迈博药业（2181）1月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1135557592","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135557592?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:51","pubTimestamp":1770108704,"startTime":"0","endTime":"0","summary":"迈博药业有限公司于2026年2月3日提交的月报显示，本次报告期为2026年1月，期内公司股本结构及发行情况保持稳定。公告称，公司注册股本为50,000,000,000股，面值为每股0.0001美元，总额维持在5,000,000美元。截至1月31日，普通股已发行股数为4,124,080,000股，与上一个月份持平，库藏股数量为零。\n报告并披露，公司购股权计划期末未行使的购股权数量为72,670,876份，且本月内无新增发行、行使及注销。公司确认截至本月底，其满足香港联交所所要求的最低公众持股量规定。\n公司同时说明，本月无购回或注销股票活动，股本总数未发生变化。公告由公司秘书曾浩贤先生签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603573467","title":"迈博药业-B盘中异动 股价大跌9.09%报0.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603573467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603573467?lang=zh_cn&edition=full","pubTime":"2026-01-12 10:30","pubTimestamp":1768185054,"startTime":"0","endTime":"0","summary":"2026年01月12日早盘10时30分，迈博药业-B股票出现异动，股价大幅下跌9.09%。截至发稿，该股报0.500港元/股，成交量17.2万股，换手率0.00%，振幅9.09%。资金方面，该股资金流入8.8万港元，流出6000港元。迈博药业-B股票所在的生物技术行业中，整体涨幅为1.21%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事癌症及自身免疫性疾病的单抗药物的研究、开发及生产的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112103054a70f9a7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112103054a70f9a7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02181","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602906323","title":"迈博药业-B盘中异动 快速拉升5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602906323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602906323?lang=zh_cn&edition=full","pubTime":"2026-01-09 09:47","pubTimestamp":1767923234,"startTime":"0","endTime":"0","summary":"2026年01月09日早盘09时47分，迈博药业-B股票出现异动，股价快速上涨5.77%。截至发稿，该股报0.550港元/股，成交量9.4万股，换手率0.00%，振幅1.92%。迈博药业-B股票所在的生物技术行业中，整体跌幅为2.11%。其相关个股中，瑞博生物-B、博安生物、迈博药业-B涨幅较大，振幅较大的相关个股有拨康视云-B、瑞博生物-B、博安生物，振幅分别为18.86%、16.47%、9.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109094714a7050da4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109094714a7050da4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123586931","title":"迈博药业（02181）更新2025年12月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1123586931","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123586931?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:43","pubTimestamp":1767602597,"startTime":"0","endTime":"0","summary":"迈博药业有限公司（02181）于2026年1月5日发布截至2025年12月31日的股份变动月报。报告显示，公司法定股本维持在50,000,000,000股，面值每股0.0001美元，注册股本总额5,000,000美元，较上月无变化。\n报告期内，公司已发行股份总数为4,124,080,000股，与上月底持平。无新增发行、购回或注销活动，库存股份保持在零股水平。此外，公司的购股权计划下仍有72,670,876份购股权，截至报告期末数量亦无变化。\n公司确认，截至2025年12月31日，整体股本结构维持稳定。公告由公司秘书曾浩贤先生代表提交。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595768990","title":"迈博药业-B盘中异动 早盘大幅下挫9.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595768990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595768990?lang=zh_cn&edition=full","pubTime":"2025-12-30 10:36","pubTimestamp":1767062185,"startTime":"0","endTime":"0","summary":"2025年12月30日早盘10时36分，迈博药业-B股票出现波动，股价急速下挫9.26%。截至发稿，该股报0.490港元/股，成交量1.2万股，换手率0.00%，振幅0.00%。迈博药业-B股票所在的生物技术行业中，整体跌幅为0.91%。其相关个股中，帝王国际投资、药捷安康-B、华昊中天医药-B涨幅较大，振幅较大的相关个股有药捷安康-B、华昊中天医药-B、帝王国际投资，振幅分别为20.71%、17.58%、16.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230103625953bccd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230103625953bccd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02181","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593432391","title":"迈博药业-B盘中异动 早盘股价大涨5.66%报0.560港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593432391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593432391?lang=zh_cn&edition=full","pubTime":"2025-12-22 11:01","pubTimestamp":1766372509,"startTime":"0","endTime":"0","summary":"2025年12月22日早盘11时01分，迈博药业-B股票出现波动，股价大幅上涨5.66%。截至发稿，该股报0.560港元/股，成交量0股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出0港元。迈博药业-B股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，北海康成-B、迈博药业-B、百奥赛图-B涨幅较大，振幅较大的相关个股有华生物-B、加科思-B、云康集团，振幅分别为16.23%、14.35%、14.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222110149a4687030&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222110149a4687030&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126023348","title":"迈博药业（02181）11月无新增发行或变动，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1126023348","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126023348?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:36","pubTimestamp":1764750970,"startTime":"0","endTime":"0","summary":"迈博药业有限公司于2025年12月3日向香港联合交易所有限公司提交的最新月报表显示，截至2025年11月30日，公司注册股本及已发行股份总数均与上月保持一致，未发生新增发行、购回、注销或库藏股份等变动。公司公告显示，迈博药业注册股本为50,000,000,000股普通股，面值每股0.0001美元，注册资本总额续维持5,000,000美元不变；已发行股本为4,124,080,000股普通股，无任何购回或新增发行活动。公告同时确认，截至本月末，公司股本及股权结构保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114028107","title":"港股生物医药股午后跌幅持续扩大，歌礼制药-B跌超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114028107","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114028107?lang=zh_cn&edition=full","pubTime":"2025-12-03 13:12","pubTimestamp":1764738746,"startTime":"0","endTime":"0","summary":"12月3日，港股生物医药股午后跌幅持续扩大，$歌礼制药-B(01672)$跌超11%，$华领医药-B(02552)$跌近8%，$迈博药业-B(02181)$跌近7%，$德琪医药-B(06996)$跌超5%，$亚盛医药-B(06855)$跌超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c54c8d8de852bbfb4567c558a904e399","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","01672","06996","BK1583","BK1161","06855","02181","BK1574","01477","02552","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583547930","title":"迈博药业-B盘中异动 股价大涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583547930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583547930?lang=zh_cn&edition=full","pubTime":"2025-11-14 09:56","pubTimestamp":1763085407,"startTime":"0","endTime":"0","summary":"2025年11月14日早盘09时56分，迈博药业-B股票出现异动，股价大幅上涨5.77%。截至发稿，该股报0.550港元/股，成交量4000股，换手率0.00%，振幅5.77%。迈博药业-B股票所在的生物技术行业中，整体跌幅为2.39%。其相关个股中，迈博药业-B、基石药业-B、思路迪医药股份涨幅较大，振幅较大的相关个股有嘉和生物-B、帝王国际投资、永泰生物-B，振幅分别为10.03%、9.46%、9.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114095648a4a047db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114095648a4a047db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518630227","title":"迈博药业-B盘中异动 下午盘股价大跌9.43%报0.480港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518630227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518630227?lang=zh_cn&edition=full","pubTime":"2025-03-11 14:02","pubTimestamp":1741672972,"startTime":"0","endTime":"0","summary":"2025年03月11日下午盘14时02分，迈博药业-B股票出现异动，股价急速跳水9.43%。截至发稿，该股报0.480港元/股，成交量2000股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出960港元。迈博药业-B股票所在的生物技术行业中，整体涨幅为0.74%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311140252a1d44d54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311140252a1d44d54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518825121","title":"迈博药业-B股价重挫18.64% 市值跌3.69亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518825121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518825121?lang=zh_cn&edition=full","pubTime":"2025-03-10 10:01","pubTimestamp":1741572115,"startTime":"0","endTime":"0","summary":"2025年03月10日早盘10时01分，迈博药业-B股票出现波动，股价急速跳水18.64%。截至发稿，该股报0.480港元/股，成交量2万股，换手率0.00%，振幅0.00%。资金方面，该股资金流入9600港元，流出0港元。迈博药业-B股票所在的生物技术行业中，整体跌幅为0.97%。迈博药业-B公司简介：迈博药业有限公司是一家主要从事研究、开发和生产用于癌症和自身免疫疾病的单克隆抗体药物的中国公司。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310100155a2692f93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310100155a2692f93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","02181"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mabpharm.cn","stockEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.1},{"period":"3month","weight":-0.1346},{"period":"6month","weight":-0.1346},{"period":"1year","weight":0.0465},{"period":"ytd","weight":-0.1}],"compareEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0437},{"period":"3month","weight":-0.025},{"period":"6month","weight":-0.0011},{"period":"1year","weight":0.1567},{"period":"ytd","weight":0.0228}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"迈博药业有限公司是一家主要从事癌症及自身免疫性疾病的单抗药物的研究、开发及生产的投资控股公司。该公司的主要产品包括CMAB009恩立妥（西妥昔单抗β注射液）、CMAB007奥迈舒（注射用奥马珠单抗α）、CMAB008类停（注射用英夫利西单抗）等产品。该公司的产品主要应用于结直肠癌、哮喘、荨麻疹、类风湿关节炎、成人溃疡性结肠炎等疾病。该公司还从事知识产权转让。该公司主要在中国市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.042254},{"month":2,"riseRate":0.714286,"avgChangeRate":0.036832},{"month":3,"riseRate":0.857143,"avgChangeRate":0.222845},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.093381},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.038423},{"month":6,"riseRate":0.571429,"avgChangeRate":0.08413},{"month":7,"riseRate":0.428571,"avgChangeRate":0.039779},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.059781},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.082167},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.006824},{"month":11,"riseRate":0.571429,"avgChangeRate":0.003391},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.022132}],"exchange":"SEHK","name":"迈博药业-B","nameEN":"MABPHARM-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈博药业-B(02181)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈博药业-B(02181)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈博药业-B,02181,迈博药业-B股票,迈博药业-B股票老虎,迈博药业-B股票老虎国际,迈博药业-B行情,迈博药业-B股票行情,迈博药业-B股价,迈博药业-B股市,迈博药业-B股票价格,迈博药业-B股票交易,迈博药业-B股票购买,迈博药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈博药业-B(02181)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈博药业-B(02181)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}